February 27, 2026 · Form 4 insider transaction
Bozic Carmen sold 2,329 shares of Vertex Pharmaceuticals Incorporated at $480.31 per share, a transaction worth $1.12M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 11/20/2025.